Expanded Access of Occlutech's Atrial Flow Regulator

Part of paid clinical trials in Maple Grove, Minnesota.

Sponsor
Occlutech International AB
Study ID
NCT07421557
Status
Available

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Catheter implantation of Occlutech AFR device — DEVICE

Study Details

Occlutech AFR use allowed per FDA's Expanded Access program.

Key Dates

First listed
Feb 19, 2026
Status verified
Feb 2026

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Individual Sites Across the U.S.Maple GroveMinnesota55369-

Find similar trials in Maple Grove, MN